{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:55:35Z","timestamp":1784555735668,"version":"3.55.0"},"update-to":[{"DOI":"10.1016\/j.lfs.2020.118164","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118164","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T01:38:56Z","timestamp":1596159536000},"page":"118164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["RETRACTED: Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis"],"prefix":"10.1016","volume":"378","author":[{"given":"Ishnoor","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Setia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotfi","family":"Aleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118164_bb0005","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ket134","article-title":"The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis","volume":"52","author":"Chen","year":"2013","journal-title":"Rheumatology."},{"key":"10.1016\/j.lfs.2020.118164_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0091-679X(08)60104-1","article-title":"The isolation and purification of the high mobility group (HMG) non-histone chromosomal proteins","volume":"16","author":"Goodwin","year":"1977","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0079-6603(08)60360-8","article-title":"High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function","volume":"54","author":"Bustin","year":"1996","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0020","first-page":"231","article-title":"Structural features of the HMG chromosomal proteins and their genes","volume":"1049","author":"Bustin","year":"1990","journal-title":"Biochem. Biophys. Acta."},{"key":"10.1016\/j.lfs.2020.118164_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mc.20544","article-title":"HMGB1: the jack-of all-trades protein is a master DNA repair mechanic","volume":"48","author":"Lange","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2020.118164_bb0030","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/MCB.18.8.4471","article-title":"High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells","volume":"18","author":"Boonyaratanakornkit","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/10338","article-title":"The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice","volume":"22","author":"Calogero","year":"1999","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.lfs.2020.118164_bb0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jmb.2007.09.073","article-title":"HMGB binding to DNA: single and double box motifs","volume":"374","author":"McCauley","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0045","article-title":"The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail","author":"Gong","year":"2010","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2020.118164_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science."},{"key":"10.1016\/j.lfs.2020.118164_bb0055","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of tolllike receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118164_bb0060","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","article-title":"HMG-1 as a mediator of acute lung inflammation","volume":"165","author":"Abraham","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1600-6143.2007.01734.x","article-title":"Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection","volume":"7","author":"Huang","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2020.118164_bb0070","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1073\/pnas.0810169106","article-title":"Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation","volume":"106","author":"Kruger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118164_bb0075","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00109-010-0681-7","article-title":"High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice","volume":"88","author":"Gong","year":"2010","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.lfs.2020.118164_bb0080","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.4049\/jimmunol.0900504","article-title":"Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells","volume":"183","author":"Lotfi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0085","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1089\/ars.2010.3341","article-title":"High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle","volume":"15","author":"Vezzoli","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118164_bb0090","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.4049\/jimmunol.181.6.4240","article-title":"High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding tophosphatidylserine","volume":"181","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0095","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Tang","year":"2010","journal-title":"Oncogene."},{"key":"10.1016\/j.lfs.2020.118164_bb0100","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1083\/jcb.200911078","article-title":"Endogenous HMGB1 regulates autophagy","volume":"190","author":"Tang","year":"2010","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","article-title":"Induction of immunological tolerance by apoptotic cells requires caspase- dependent oxidation of highmobility group box-1 protein","volume":"29","author":"Kazama","year":"2008","journal-title":"Immunity."},{"key":"10.1016\/j.lfs.2020.118164_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/08916930902831803","article-title":"Oxidation ofthe alarmin high-mobility group box 1 protein (HMGB1) during apoptosis","volume":"42","author":"Urbonaviciute","year":"2009","journal-title":"Autoimmunity."},{"key":"10.1016\/j.lfs.2020.118164_bb0115","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4161\/auto.6.8.13651","article-title":"HMGB1: a novel Beclin 1-binding protein active in autophagy","volume":"6","author":"Kang","year":"2010","journal-title":"Autophagy."},{"key":"10.1016\/j.lfs.2020.118164_bb0120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4161\/auto.7.8.15704","article-title":"HMGB1 as an autophagy sensor in oxidative stress","volume":"7","author":"Kang","year":"2011","journal-title":"Autophagy."},{"key":"10.1016\/j.lfs.2020.118164_bb0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/07853899709007474","article-title":"Pro- and anti-inflammatory cytokines in rheumatoid arthritis","volume":"29","author":"Isomaki","year":"1997","journal-title":"Ann. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0130","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.25011\/cim.v34i5.15673","article-title":"Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis","volume":"34","author":"Li","year":"2011","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0135","article-title":"Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life","author":"Oktayoglu","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.lfs.2020.118164_bb0140","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/art.10540","article-title":"High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis","volume":"46","author":"Kokkola","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","article-title":"High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine","volume":"48","author":"Taniguchi","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","article-title":"Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis","volume":"13","author":"Goldstein","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0155","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.11028","article-title":"High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis","volume":"48","author":"Pullerits","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0160","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/art.27590","article-title":"Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model","volume":"62","author":"Ostberg","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/295081","article-title":"Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis","volume":"2012","author":"Shi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-3083.2012.02759.x","article-title":"HMGB1 promotes the differentiation of Th17 via up-regulating TLR2 and IL-23 of CD14 (+) monocytes from patients with rheumatoid arthritis","volume":"76","author":"He","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2003.01303.x","article-title":"HMGB1 is a potent trigger of arthritis","volume":"255","author":"Andersson","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0180","series-title":"The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis","author":"Biscetti","year":"2017"},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0185","first-page":"629","article-title":"Rheumatoid arthritis:what have we learned about the causing factors?","volume":"29","author":"Jalil","year":"2016","journal-title":"Pakistan Journal of Pharmaceutical Sciencesvol."},{"key":"10.1016\/j.lfs.2020.118164_bb0190","article-title":"The role of endostatin in rheumatoid arthritis","author":"Behl","year":"2020","journal-title":"Curr. Rheumatol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0195","first-page":"144","article-title":"Biomarkers in rheumatoid arthritis, what is new?","volume":"9","author":"Gavril\u0103","year":"2016","journal-title":"Journal of Medicine and Life."},{"issue":"5","key":"10.1016\/j.lfs.2020.118164_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5694\/mja16.01287","article-title":"Advances in rheumatoid arthritis","volume":"206","author":"Jones","year":"2017","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.lfs.2020.118164_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-017-0643-y","article-title":"Managing cardiovascular disease risk in rheumatoid arthritis: clinical updates and three strategic approaches","volume":"19","author":"Chodara","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tcm.2016.07.006","article-title":"Cardiovascular disease in patients with rheumatoid arthritis","volume":"27","author":"Liao","year":"2017","journal-title":"Trends in Cardiovascular Medicine."},{"key":"10.1016\/j.lfs.2020.118164_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12999","article-title":"New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis","volume":"20","author":"Mahmoudi","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2020.118164_bb0220","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-015-0550-z","article-title":"The obesity epidemic and consequences for rheumatoid arthritis care","volume":"18","author":"George","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"7","key":"10.1016\/j.lfs.2020.118164_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040362","article-title":"Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis","volume":"7","author":"Ferraccioli","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2020.118164_bb0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/BOR.0b013e3283477b7b","article-title":"Infection and rheumatoid arthritis: still an open question","volume":"23","author":"Hitchon","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118164_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rdc.2015.08.006","article-title":"Glucocorticoids and rheumatoid arthritis","volume":"42","author":"Ferreira","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.lfs.2020.118164_bb0245","first-page":"S40","article-title":"From genetics to functional insights into rheumatoid arthritis","volume":"33","author":"Suzuki","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.lfs.2020.118164_bb0250","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.1038\/ncomms12970","article-title":"MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis","volume":"7","author":"Alivernini","year":"2016","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.lfs.2020.118164_bb0255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrrheum.2016.52","article-title":"Family history of rheumatoid arthritis: an old concept with new developments","volume":"12","author":"Frisell","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118164_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-016-0563-2","article-title":"The roles of cigarette smoking and the lung in the transitions between phases of preclinical rheumatoid arthritis","volume":"18","author":"Sparks","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2020.118164_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.12966","article-title":"The role of IL-6 signaling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis","volume":"189","author":"Schinnerling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118164_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.lfs.2020.118164_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.lfs.2020.118164_bb0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbagrm.2009.11.005","article-title":"HMGB proteins and transcriptional regulation","volume":"1799","author":"Ueda","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.118164_bb0290","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1101\/gad.12.4.462","article-title":"High mobility group protein-1 (HMG-1) is a unique activator of p53","volume":"12","author":"Jayaraman","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2020.118164_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bj3610097","article-title":"Comparative analysis of the influence of the high-mobility group Box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors","volume":"361","author":"Verrijdt","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2020.118164_bb0300","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1128\/MCB.25.11.4413-4425.2005","article-title":"Determinants of HMGB proteins required to promote RAG1\/2-recombination signal sequence complex assembly and catalysis during V(D)J recombination","volume":"25","author":"Dai","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2020.118164_bb0305","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High Mobility Group Box Protein 1 (HMGB1): the prototypical endogenous danger molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0310","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2119\/molmed.2013.00117","article-title":"\u03b17 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release","volume":"20","author":"Lu","year":"2014","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"ScaffidI","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118164_bb0320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrm2617","article-title":"Mechanisms of regulated unconventional protein secretion","volume":"10","author":"Nickel","year":"2009","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0325","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0330","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/37022","article-title":"Immunosuppressive effects of apoptotic cells","volume":"390","author":"VolI","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118164_bb0335","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1152\/ajpcell.00616.2005","article-title":"The extracellular release of HMGB1 during apoptotic cell death","volume":"291","author":"Bell","year":"2006","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118164_bb0340","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2006.04.016","article-title":"New high mobility group Box 1 assay system","volume":"372","author":"Yamada","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2020.118164_bb0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1189\/jlb.0306196","article-title":"Factors masking HMGB1 in human serum and plasma","volume":"81","author":"Urbonaviciute","year":"2007","journal-title":"J. Leukoc. Bioi."},{"key":"10.1016\/j.lfs.2020.118164_bb0355","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/toxsci\/kfp235","article-title":"High mobility group Box 1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo","volume":"112","author":"Antoine","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2020.118164_bb0360","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.1316925111","article-title":"JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.lfs.2020.118164_bb0365","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"Yang","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbagrm.2009.09.008","article-title":"HMGB proteins: interactions with DNA and chromatin","volume":"1799","author":"\u0160tros","year":"2010","journal-title":"Biochim. Biophys. Acta. Gene Regul. Mech."},{"key":"10.1016\/j.lfs.2020.118164_bb0375","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","article-title":"Extracellular HMGB1 as a therapeutic target in inflammatory diseases","volume":"22","author":"Andersson","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2020.118164_bb0380","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172487","article-title":"Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: updates on receptor signaling","volume":"858","author":"Paudel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"MD-2 is required for disulfide HMGB1\u2013dependent TLR4 signaling","volume":"212","author":"Yang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076039","article-title":"Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue","volume":"8","author":"Nativel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118164_bb0400","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0405","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000487056","article-title":"Neuroinflammation in response to intracerebral injections of different HMGB1 redox isoforms","volume":"10","author":"Aucott","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.lfs.2020.118164_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2018.02.011","article-title":"High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells","author":"Andersson","year":"2018","journal-title":"Semin. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118164_bb0415","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/ars.2015.6409","article-title":"Regulation of posttranslational modifications of HMGB1 during immune responses","volume":"24","author":"Tang","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118164_bb0420","doi-asserted-by":"crossref","unstructured":"J. Evankovich, et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J. Biol. Chem. 51 (285) 39888\u2013398897.","DOI":"10.1074\/jbc.M110.128348"},{"key":"10.1016\/j.lfs.2020.118164_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/srep15971","article-title":"Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia","volume":"5","author":"Hwang","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2020.118164_bb0430","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein HMGB1 is secreted by monocytes via a nonclassical vesicle-mediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/viru.2.2.15480","article-title":"HMGB1 release by inflammasomes","volume":"2","author":"Walle","year":"2011","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.lfs.2020.118164_bb0440","first-page":"1087","article-title":"Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation","volume":"84","author":"Rouhiainen","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.lfs.2020.118164_bb0445","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1172\/JCI81660","article-title":"Platelet-derived HMGB1 is a critical mediator of thrombosis","volume":"125","author":"Vogel","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.lfs.2020.118164_bb0450","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2016-04-710632","article-title":"Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice","volume":"128","author":"Stark","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lfs.2020.118164_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","article-title":"Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein","volume":"29","author":"Kazama","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2020.118164_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","article-title":"HMGB1 in health and disease","volume":"40","author":"Kang","year":"2014","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0465","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0470","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.lfs.2020.118164_bb0475","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1172\/JCI92001","article-title":"Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy","volume":"127","author":"Walker","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118164_bb0480","first-page":"4805","article-title":"Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis","volume":"62","author":"Huttunen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118164_bb0485","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","article-title":"Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells","volume":"101","author":"Fiuza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.118164_bb0490","series-title":"Seminars in Immunology","first-page":"40","article-title":"High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells","author":"Andersson","year":"2018"},{"key":"10.1016\/j.lfs.2020.118164_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2005.01534.x","article-title":"RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages","volume":"61","author":"Kokkola","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0500","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00011-010-0208-2","article-title":"Important aspects of Toll-like receptors, ligands and their signaling pathways","volume":"59","author":"Chang","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2020.118164_bb0505","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran","volume":"130","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118164_bb0510","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.lfs.2020.118164_bb0515","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s10020-018-0023-8","article-title":"Exploring the biological functional mechanism of the HMGB1\/TLR4\/MD-2 complex by surface plasmon resonance","volume":"24","author":"He","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0520","first-page":"1","article-title":"Mechanistic insights into high mobility group box-1 (HMGb1) induced toll-like receptor 4 (TLR4) dimer formation","author":"Sun","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2020.118164_bb0525","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ni.2396","article-title":"Tumor immunity times out: TIM-3 and HMGB1","volume":"13","author":"Tang","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0530","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","article-title":"CD24 and Siglec-10 selectively repress tissue damage\u2013induced immune responses","volume":"323","author":"Chen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118164_bb0535","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.apcsb.2016.10.001","article-title":"HMGB1 protein: a therapeutic target inside and outside the cell","volume":"vol. 37","author":"Ugrinova","year":"2017"},{"key":"10.1016\/j.lfs.2020.118164_bb0540","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0545","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jchromb.2006.08.012","article-title":"An improved method for haptoglobin 1-1, 2-1, and 2-2 purification using monoclonal antibody affinity chromatography in the presence of sodium dodecyl sulfate","volume":"845","author":"Yueh","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"7","key":"10.1016\/j.lfs.2020.118164_bb0550","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85375","article-title":"Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes","volume":"1","author":"Yang","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.lfs.2020.118164_bb0555","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0952-7915(00)00269-7","article-title":"Immunotherapy for rheumatoid arthritis","volume":"13","author":"Taylor","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0560","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/eji.201444908","article-title":"HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1\u03b1 activation","volume":"45","author":"Park","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0565","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesiclemediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lfs.2020.118164_bb0570","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00024382-200115040-00001","article-title":"HMG-1 rediscovered as a cytokine","volume":"15","author":"Yang","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2020.118164_bb0575","first-page":"1","article-title":"Downregulated brain-derived neurotrophic factor-induced oxidative stress in the pathophysiology of diabetic retinopathy","author":"Behl","year":"2016","journal-title":"Can. J. Diabetes xxx"},{"key":"10.1016\/j.lfs.2020.118164_bb0580","article-title":"Exploration of combined effect of peroxisome proliferator activated receptor (PPAR) agonist and retinoic acid receptor (RAR) agonist on experimental models of inflammation in rats","author":"Kakkar","year":"2020","journal-title":"OBMED"},{"issue":"2","key":"10.1016\/j.lfs.2020.118164_bb0585","first-page":"45","article-title":"Role of HDAC inhibitors in diabetic mellitus","volume":"8","author":"Makkar","year":"2019","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0590","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous HMGB1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2020.118164_bb0595","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20052203","article-title":"Role of HMGB1 in apoptosis-mediated sepsis lethality","volume":"203","author":"Qin","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0600","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/art.23729","article-title":"Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis","volume":"58","author":"Hamada","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.lfs.2020.118164_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-017-0182-x","article-title":"HMGB proteins and arthritis","volume":"31","author":"Taniguchi","year":"2018","journal-title":"Hum. Cell."},{"key":"10.1016\/j.lfs.2020.118164_bb0610","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2017.00195","article-title":"Expansions of cytotoxic CD4+ CD28\u2212 T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection","volume":"8","author":"Broadley","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.118164_bb0615","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.11161","article-title":"Successful therapy in collagen-induced arthritis in mice and rats targeting extracellular HMGB1 activity","volume":"48","author":"Kokkola","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0620","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/ar3124","article-title":"High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1\u03b2 in osteoarthritic synoviocytes","volume":"12","author":"Garc\u00eda-Arnandis","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2020.118164_bb0625","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.22707","article-title":"Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis","volume":"56","author":"Huang","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0630","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1189\/jlb.0908548","article-title":"The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation","volume":"86","author":"Hreggvidsdottir","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0635","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar2155","article-title":"Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis","volume":"9","author":"Palmblad","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2020.118164_bb0640","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0609.2007.00981.x","article-title":"Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU","volume":"80","author":"Mouri","year":"2008","journal-title":"1. Eur. J. Haematol."},{"key":"10.1016\/j.lfs.2020.118164_bb0645","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar2440","article-title":"High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease","volume":"10","author":"Pisetsky","year":"2008","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.lfs.2020.118164_bb0650","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.11161","article-title":"Successful treatment ofcollagen-induced arthritis in mice and rats by targeting extracellularhigh mobility group box chromosomal protein 1 activity","volume":"48","author":"Kokkola","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118164_bb0655","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobilitygroup box 1 monoclonal antibody ameliorates brain infarctioninduced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2020.118164_bb0660","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenoushigh-mobility group box 1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118164_bb0665","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptorfor advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0670","doi-asserted-by":"crossref","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","article-title":"The extracellular release of HMGB1 during apoptotic cell death","volume":"291","author":"Bell","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2020.118164_bb0675","doi-asserted-by":"crossref","DOI":"10.1186\/cc6184","article-title":"Inhibition of the RAGE products increases survivalin experimental models of severe sepsis and systemicinfection","volume":"11","author":"Lutterloh","year":"2007","journal-title":"Crit. Care"},{"key":"10.1016\/j.lfs.2020.118164_bb0680","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118164_bb0685","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1538-7836.2006.02033.x","article-title":"The lectin-like domain ofthrombomodulin interferes with complement activation andprotects against arthritis","volume":"4","author":"Van de Wouwer","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.118164_bb0690","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar2347","article-title":"Oxaliplatin retains HMGB1intranuclearly and ameliorates collagen type II-induced arthritis","volume":"10","author":"Ostberg","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2020.118164_bb0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0507323","article-title":"Pivotal advance: inhibition of HMGB1 nucleartranslocation as a mechanism for the anti-rheumatic effectsof gold sodium thiomalate","volume":"83","author":"Schierbeck","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2020.118164_bb0700","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic anti-inflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118164_bb0705","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","article-title":"Cholinergicanti-inflammatory pathway activity and High MobilityGroup Box-1 (HMGB1) serum levels in patients with rheumatoidarthritis","volume":"13","author":"Goldstein","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0710","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar2387","article-title":"Systemic TNF blockadedoes not modulate synovial expression of the pro-inflammatorymediator HMGB1 in rheumatoid arthritis patients \u2013 a prospective clinical study","volume":"10","author":"Sundberg","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2020.118164_bb0715","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118164_bb0720","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/CEOR.S91006","article-title":"Costs associated with rheumatoid arthritis in Italy: past, present, and future","volume":"8","author":"Benucci","year":"2016","journal-title":"ClinicoEconomics and Outcomes Research"},{"key":"10.1016\/j.lfs.2020.118164_bb0725","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03402105","article-title":"Structural basis for the proinflammatory cytokine activity of high mobility group box 1 (HMGB1)","volume":"9","author":"Li","year":"2003","journal-title":"Mol. Med."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2025.123838","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000}},{"DOI":"10.1016\/j.lfs.2020.118164","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}},{"DOI":"10.1016\/j.lfs.2025.123838","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"record-id":"67869"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520309164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520309164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T15:21:14Z","timestamp":1751210474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520309164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":144,"alternative-id":["S0024320520309164"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118164","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.lfs.2020.118164","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118164"}}